{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T04:52:20Z","timestamp":1789447940099,"version":"build-2803163510"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T00:00:00Z","timestamp":1566432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Bloomberg American Health Initiative"},{"name":"Johns Hopkins University Center for AIDS Research","award":["1P30AI094189"],"award-info":[{"award-number":["1P30AI094189"]}]},{"DOI":"10.13039\/100000026","name":"National Institute for Drug Abuse","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.drugalcdep.2019.107547","type":"journal-article","created":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T11:33:06Z","timestamp":1566559986000},"page":"107547","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"special_numbering":"C","title":["Preference for drugs containing fentanyl from a cross-sectional survey of people who use illicit opioids in three United States cities"],"prefix":"10.1016","volume":"204","author":[{"given":"Kenneth B.","family":"Morales","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju Nyeong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Glick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saba","family":"Rouhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Traci C.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan G.","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2019.107547_bib0005","first-page":"1","article-title":"Why the FUSS (Fentanyl Urine Screen Study)? A cross-sectional survey to characterize an emerging threat to people who use drugs in British Columbia","volume":"12","author":"Amlani","year":"2015","journal-title":"Canada. Harm Reduct. J."},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0010","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1001\/jamainternmed.2016.4306","article-title":"Adverse effects from counterfeit alprazolam tablets","volume":"176","author":"Arens","year":"2016","journal-title":"JAMA Int. Med."},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0015","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neuropharm.2017.10.016","article-title":"Fentanyl, fentanyl analogs and novel synthetic opioids: a comprehensive review","volume":"134","author":"Armenian","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0020","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.drugpo.2017.05.023","article-title":"Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode Island: a mixed methods study","volume":"46","author":"Carroll","year":"2017","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0025","series-title":"CDC WONDER Online Database","article-title":"Multiple cause of death 1999-2016 [WWW document]","author":"Centers for Disease Control","year":"2018"},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0030","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.drugpo.2017.06.010","article-title":"Fentanyl in the US heroin supply: a rapidly changing risk environment","volume":"46","author":"Ciccarone","year":"2017","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0035","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.drugpo.2008.08.003","article-title":"Heroin in brown, black and white: structural factors and medical consequences in the US heroin market","volume":"20","author":"Ciccarone","year":"2009","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0040","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.drugpo.2017.06.004","article-title":"Heroin uncertainties: exploring users\u2019 perceptions of fentanyl-adulterated and -substituted \u201cheroin.\u201d","volume":"46","author":"Ciccarone","year":"2017","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0045","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.addbeh.2018.05.030","article-title":"Increased use of heroin as an initiating opioid of abuse: further considerations and policy implications","volume":"87","author":"Cicero","year":"2018","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0050","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/sj.npp.1301479","article-title":"Abuse liability of prescription opioids compared to heroin in morphine-maintained heroin abusers","volume":"33","author":"Comer","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0055","series-title":"National Heroin Threat Assessment Summary","author":"DEA Strategic Intelligence Section","year":"2015"},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0060","series-title":"Fentanyl Remains the Most Significant Synthetic Opioid Threat and Poses the Greatest Threat to the Opioid User Market in the United States","author":"Drug Enforcement Administration: Strategic Intelligence Section","year":"2018"},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0065","series-title":"Counterfeit Prescription Pills Containing Fentanyls: A Global","author":"Drug Enforcement Administration: Strategic Intelligence Section","year":"2016"},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0070","series-title":"DEA Fact Sheet: Fentanyl","author":"Drug Enforcement Administration","year":"2016"},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0075","series-title":"National Forensic Laboratory Information System: 2015 Annual Report. Washington, DC","author":"Drug Enforcement Administration, D.C.D","year":"2015"},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0080","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.drugpo.2008.02.016","article-title":"Fentanyl use among street drug users in Toronto, Canada: behavioural dynamics and public health implications","volume":"20","author":"Firestone","year":"2009","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0085","doi-asserted-by":"crossref","first-page":"837","DOI":"10.15585\/mmwr.mm6533a2","article-title":"Fentanyl law enforcement submissions and increases in synthetic opioid\u2013involved overdose deaths \u2014 27 states, 2013\u20132014","volume":"65","author":"Gladden","year":"2016","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0090","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.drugalcdep.2018.10.017","article-title":"Stakeholder perspectives on implementing fentanyl drug checking - results from a multi-site study","volume":"194","author":"Glick","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0095","first-page":"2127","article-title":"Is the prescription opioid epidemic a white problem? Am","volume":"106","author":"Hansen","year":"2016","journal-title":"J. Public Health (Bangkok)"},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0100","series-title":"The Global State of Harm Reduction. Harm Reduction International","author":"Harm Reduction International","year":"2016"},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0105","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/hec.2937","article-title":"Supply-side response to declining heroin purity: fentanyl overdose episode in New Jersey","volume":"23","author":"Hempstead","year":"2014","journal-title":"Health Econ."},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0110","series-title":"Falling Out","author":"Jamison","year":"2018"},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0115","series-title":"Reviews the Fentanyl Epidemic and Evolution of Fentanyl Analogs in the United States and the European Union 253","author":"Jannetto","year":"2019"},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0120","first-page":"1","article-title":"Evaluation of a fentanyl drug checking service for clients of a supervised injection facility, Vancouver, Canada","volume":"15","author":"Karamuzian","year":"2018","journal-title":"Harm Reduct. J."},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2018.06.010","article-title":"New synthetic opioids: part of a new addiction landscape","author":"Karila","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0130","series-title":"The Opioid Crisis Is Getting Worse, Particularly for Black Americans","author":"Katz","year":"2017"},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0135","series-title":"Mortality in the United States","author":"Kochanek","year":"2017"},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0140","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/1060028015625659","article-title":"Opioid pharmacokinetics-pharmacodynamics: clinical implications in acute pain management in trauma","volume":"50","author":"MacKenzie","year":"2016","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0145","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.addbeh.2017.01.014","article-title":"Prevalence and correlates of fentanyl-contaminated heroin exposure among young adults who use prescription opioids non-medically","volume":"68","author":"Macmadu","year":"2017","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0150","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/jat\/bku086","article-title":"A series of forensic toxicology and drug seizure cases involving illicit fentanyl alone and in combination with heroin, cocaine or heroin and cocaine","volume":"38","author":"Marinetti","year":"2014","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0155","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1080\/02791072.2016.1207826","article-title":"The textures of heroin: user perspectives on \u201cblack tar\u201d and powder heroin in two U. S. Cities","volume":"48","author":"Mars","year":"2016","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0160","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.socscimed.2015.06.032","article-title":"Heroin-related overdose : the unexplored influences of markets, marketing and source-types in the United States","volume":"140","author":"Mars","year":"2015","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0165","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/02791072.2017.1394508","article-title":"Sold as heroin: perceptions and use of an evolving drug in Baltimore, MD","volume":"50","author":"Mars","year":"2018","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0170","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.drugpo.2017.05.029","article-title":"Epidemiology of fentanyl-involved drug overdose deaths: a geospatial retrospective study in Rhode island","volume":"46","author":"Marshall","year":"2017","journal-title":"USA. Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0175","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/wps.20350","article-title":"Nonmedical use of prescription drugs in adolescents and young adults: not just a Western phenomenon","volume":"16","author":"Martins","year":"2017","journal-title":"World Psychiatry"},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0180","series-title":"Drug-and Alcohol-Related Intoxication Deaths in Maryland, 2016","author":"Maryland Department of Health and Mental Hygiene","year":"2017"},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0185","series-title":"Data Brief: Opioid-related Overdose Deaths Among Massachusetts Residents","author":"Massachusetts Department of Public Health","year":"2016"},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0190","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s0054000040082","article-title":"Diazepam prevents fentanyl-induced muscle rigidity","volume":"4","author":"Mayumi","year":"1990","journal-title":"J. Anesth."},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0195","series-title":"Recent Deaths Possibly Linked to Fentanyl. London","author":"National Crime Agency","year":"2017"},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0200","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1057\/biosoc.2015.46","article-title":"White opioids: pharmaceutical race and the war on drugs that wasn\u2019t","volume":"12","author":"Netherland","year":"2017","journal-title":"Biosocieties"},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0205","doi-asserted-by":"crossref","first-page":"298","DOI":"10.2105\/AJPH.2015.302972","article-title":"Initiation of heroin and prescription opioid pain relievers by birth cohort","volume":"106","author":"Novak","year":"2016","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0210","first-page":"1","article-title":"Fentanyl-contaminated drugs and nonfatal overdose among people who inject drugs in Baltimore","volume":"15","author":"Park","year":"2018","journal-title":"MD. HRJ"},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.h2698","article-title":"Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study","volume":"350","author":"Park","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0220","first-page":"1","article-title":"Fentanyl test strips as an opioid overdose prevention strategy : findings from a syringe services program in the Southeastern United States","author":"Peiper","year":"2018","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2018.01145","article-title":"Drug interactions with new synthetic opioids","volume":"9","author":"P\u00e9rez-ma\u00f1\u00e1","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0230","series-title":"Fentanyl Drug Deaths Rise by Nearly a Third in England and Wales. Guard.","author":"Perraudin","year":"2018"},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0235","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/jama.2007.64","article-title":"Trends in opioid prescribing by race\/ethnicity for patients seeking care in US emergency departments","volume":"299","author":"Pletcher","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0240","first-page":"1","article-title":"Taking care of business - the heroin user\u2019s life on the Street","volume":"4","author":"Prebble","year":"1969","journal-title":"J. Subst. Use Misuse"},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0245","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1177\/1073110518782937","article-title":"Fentanyl: a whole new world?","volume":"46","author":"Rothberg","year":"2018","journal-title":"J. Law Med. Ethics"},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0250","first-page":"16","article-title":"Harm reduction measures employed by opioid users with suspected fentanyl exposure in Boston, Baltimore, and Providence","author":"Rouhani","year":"2019","journal-title":"Harm Reduct. J."},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0255","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/dar.12033","article-title":"Trends in fentanyl prescriptions and fentanyl-related mortality in Australia","volume":"32","author":"Roxburgh","year":"2013","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0260","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.drugpo.2019.03.003","article-title":"Acceptability of implementing community-based drug checking services for people who use drugs in three United States cities: baltimore, Boston, and Providence","volume":"68","author":"Sherman","year":"2019","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0265","series-title":"FORECAST Study Summary Report","author":"Sherman","year":"2018"},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0270","first-page":"68","article-title":"Drug overdose deaths involving fentanyl; 2011-2016","author":"Spencer","year":"2019","journal-title":"Natl. Vital Stat. Reports"},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0275","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1037\/a0035204","article-title":"Racial\/ethnic disparities in the assessment and treatment of pain","volume":"69","author":"Tait","year":"2014","journal-title":"Am. Psychol."},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0280","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.2105\/AJPH.93.12.2067","article-title":"Racial and ethnic disparities in emergency department analgesic prescription - Nursing and Allied Health Database - ProQuest","volume":"93","author":"Tamayo-Sarver","year":"2003","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0285","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1111\/add.12664","article-title":"The relationship between US heroin market dynamics and heroin-related overdose, 1992-2008","volume":"109","author":"Unick","year":"2014","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0290","series-title":"World Drug Report","doi-asserted-by":"crossref","DOI":"10.18356\/d29e3f27-en","author":"United Nations Office on Drugs and Crime","year":"2018"},{"key":"10.1016\/j.drugalcdep.2019.107547_bib0295","series-title":"Mortality in the United States, 2015. NCHS Data Brief 1\u20138","author":"Xu","year":"2016"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871619303163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871619303163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:00:22Z","timestamp":1759827622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871619303163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":59,"alternative-id":["S0376871619303163"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.107547","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preference for drugs containing fentanyl from a cross-sectional survey of people who use illicit opioids in three United States cities","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.107547","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107547"}}